Consejo Superior De Investigaciones Cientificas

Yolanda Sanz Herranz

Inmaculada Lopez Almela

Marina Romani Perez

Esther Sanchez Sanchez

Inmaculada Nadal Gimenez

Marcela Susana Medina

Moisés Laparra Llopis

Eva Ma Gomez Del Pulgar Villanueva

Ángela Moya Pérez

Alfonso Benitez-paez

Yolanda Arlette Santacruz

Paola Gauffin Cano

Giada De Palma

ÁNgela Moya PÉREZ

Ester Sanchez Sanchez

Moises Laparra Llopis

Angela Moya Perez

The present invention relates to the strain ofCECT 9752, its cellular components, metabolites, and secreted molecules, and to compositions comprising the aforementioned products, in addition to the use of said strain, but also to the genus, and to the speciesfor preventing alterations in energy homeostasis and glucose metabolism, including, glucose intolerance, insulin resistance, metabolic syndrome and diabetes.

sp. bacterium and use thereof

The invention relates to a strain ofwith registration number CECT 7771, and to the cellular constituents, metabolites and/or secreted molecules thereof. The invention also relates to a composition (nutritional or pharmaceutical) comprising at least one of the previous products. The invention further relates to the use of a strain of, preferably CECT 7771, or of the cellular constituents, metabolites and/or secreted molecules of said strain, or of a composition comprising same, for the prevention and/or treatment of alterations such as excess weight, obesity, adipocyte hypertrophy, hepatic steatosis or fatty liver, dyslipidemia, hyperglycemia, insulin resistance and diabetes, metabolic syndrome, hypertension, cardiovascular diseases, dysfunction of the immune system, reduced defenses against infections, and imbalance in the composition of the intestinal microbiota.

Bacteroides CECT 7771 and the use thereof in the prevention and treatment of excess weight, obesity and metabolic and immunological alterations

The invention relates to microorganisms for the treatment of food allergies, specifically coeliac disease, as well as to methods for the selection thereof. The action mechanisms of said microorganisms include: (i) the regulation of the innate and adaptive immunological responses; (ii) the reduction of the concentration of toxic gluten peptide epitopes in the intestinal lumen; (iii) the strengthening of the barrier defence function against harmful antigens and bacteria; and (iv) the provision of enzymatic activities that promote digestion.

Microorganisms for improving the health of individuals with disorders related to gluten ingestion

Growing community of inventors

Valencia, Spain

Yolanda Sanz Herranz